Medical Policies
Home
Search Bar
Category Filter
Policies & Guidelines
Behavioral Health
Chronic Condition Management
Hemophilia Drugs
Draft Hemophilia Drug Policies
Final Hemophilia Drug Policies
Hemophilia Drug Prior Authorization
Medical Policies
Draft Medical Policies
Final Medical Policies
Pre-Service Review (Precertification and Predetermination)
Provider-Administered Drug Policies
Draft Provider-Administered Drug Policies
Final Provider-Administered Drug Precertification Policies
Mandatory Site of Service
Provider-Administered Drug Claim Edit Policies
Voluntary Site of Service
Self-Administered Drug Policies
Draft Self-Administered Drug Policies
Final Self-Administered Drug Policies
Self-Administered Drug Prior Authorization Forms
Asset Publisher
< Back to Final Medical Policies page
Final Policies - Therapy
Policy #
Policy Title
Print View
MP-015
Sympathetic Therapy and Bioelectrical Nerve Block or Electroanalgesic Nerve Block for the Treatment of Pain
MP-019
COPES Scoliosis Treatment Recovery System
MP-028
Extracorporeal Photopheresis
MP-037
Monochromatic Infrared Energy System
MP-086
Treatment of Hyperhidrosis (Excluding Botox)
MP-100
Plasma Exchange (Plasmapheresis)
MP-103
Lipid Apheresis
MP-139
Sensory Stimulation for Brain-Injured Individuals in Coma or Vegetative State
MP-154
Manipulation under Anesthesia for Treatment of Chronic Spinal or Pelvic Pain
MP-188
Constraint-Induced Movement or Language Therapy
MP-205
Acupuncture
MP-270
Low-Level Laser Therapy
MP-333
Sensory Integration Therapy and Auditory Integration Therapy
MP-427
Hippotherapy
MP-440
Inhaled Nitric Oxide
MP-484
Vertebral Axial Decompression
MP-600
Cognitive Rehabilitation
MP-629
Medical Criteria for Osteopathic/Chiropractic Manipulative Treatment
MP-749
Dry Hydrotherapy for Chronic Pain Conditions
Hidden